Scholarlink

Background and Aims <p>Our goal was to examine the association between smoking status (current, former, and never) and prevalence of advanced findings in patients with colonoscopy after a positive multi-target stool DNA test (mt-sDNA), patients with colonoscopy after a positive Fecal Immunochemical Test (FIT), and patients with colonoscopy only (no prior stool test).</p> Methods <p>Our main outcome was prevalence of advanced lesions (any colorectal cancer (CRC), advanced adenoma, or advanced serrated polyp). We also looked at advanced adenomas and advanced serrated polyps separately. We performed logistic regressions comparing findings by smoking status within mt-sDNA + , FIT + , and colonoscopy-only patients, adjusting for age, sex, and CRC risk. We also performed logistic regressions within all current smokers comparing outcome odds between each screening method cohort.</p> Results <p>Our sample included 967 mt-sDNA + , 498 FIT + , and 58,682 colonoscopy-only patients. Within the FIT + (OR = 2.46; 95%CI 1.16–5.26) and mt-sDNA + (OR = 1.65; 95%CI 1.05–2.59) groups, current smokers had higher odds of advanced serrated polyps than never-smokers (reference). In addition, FIT + current smokers (OR = 1.97; 95%CI 1.11–3.50) or mt-sDNA (OR = 3.27; 95%CI 2.25–4.74) current smokers had higher odds of advanced lesions than colonoscopy-only smokers (reference).</p> Conclusions <p>Within stool-test-positive patients, current smokers have higher odds of advanced serrated polyps than never-smokers, reinforcing the heightened importance of a follow-up colonoscopy in smokers with positive stool tests. We also found higher yields of advanced outcomes in FIT + and mt-sDNA + smokers vs. smokers who underwent colonoscopy without a prior stool test. Endoscopists need to be particularly vigilant in detecting advanced serrated polyps in patients who smoke and have a positive stool test.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Association Between Smoking Status and Prevalence of Advanced Outcomes in Patients With and Without Positive Stool Test Prior to Colonoscopy: Data from the New Hampshire Colonoscopy Registry

  • 期刊论文

  • 发表日期：

    2025年2月20日

查看全文
  • Joseph C. Anderson,
  • William M. Hisey,
  • Christina M. Robinson,
  • Paul J. Limburg,
  • Bonny L. Kneedler,
  • Lynn F. Butterly

摘要

Background and Aims

Our goal was to examine the association between smoking status (current, former, and never) and prevalence of advanced findings in patients with colonoscopy after a positive multi-target stool DNA test (mt-sDNA), patients with colonoscopy after a positive Fecal Immunochemical Test (FIT), and patients with colonoscopy only (no prior stool test).

Methods

Our main outcome was prevalence of advanced lesions (any colorectal cancer (CRC), advanced adenoma, or advanced serrated polyp). We also looked at advanced adenomas and advanced serrated polyps separately. We performed logistic regressions comparing findings by smoking status within mt-sDNA + , FIT + , and colonoscopy-only patients, adjusting for age, sex, and CRC risk. We also performed logistic regressions within all current smokers comparing outcome odds between each screening method cohort.

Results

Our sample included 967 mt-sDNA + , 498 FIT + , and 58,682 colonoscopy-only patients. Within the FIT + (OR = 2.46; 95%CI 1.16–5.26) and mt-sDNA + (OR = 1.65; 95%CI 1.05–2.59) groups, current smokers had higher odds of advanced serrated polyps than never-smokers (reference). In addition, FIT + current smokers (OR = 1.97; 95%CI 1.11–3.50) or mt-sDNA (OR = 3.27; 95%CI 2.25–4.74) current smokers had higher odds of advanced lesions than colonoscopy-only smokers (reference).

Conclusions

Within stool-test-positive patients, current smokers have higher odds of advanced serrated polyps than never-smokers, reinforcing the heightened importance of a follow-up colonoscopy in smokers with positive stool tests. We also found higher yields of advanced outcomes in FIT + and mt-sDNA + smokers vs. smokers who underwent colonoscopy without a prior stool test. Endoscopists need to be particularly vigilant in detecting advanced serrated polyps in patients who smoke and have a positive stool test.